FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US6291495B1
(en)
|
1997-02-24 |
2001-09-18 |
Robert B. Rieveley |
Method and composition for the treatment of diabetes
|
US20020028768A1
(en)
*
|
1997-06-18 |
2002-03-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with rosiglitazone and insulin
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
US20010049380A1
(en)
*
|
1997-06-18 |
2001-12-06 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
PL195136B1
(pl)
*
|
1997-06-18 |
2007-08-31 |
Smithkline Beecham Plc |
Kombinacja zawierająca 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy]-benzylo] tiazolidyno-2,4-dion i jej zastosowanie
|
US20020016287A1
(en)
*
|
1997-07-18 |
2002-02-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
EA003101B1
(ru)
*
|
1998-03-19 |
2002-12-26 |
Бристол-Майерз Сквибб Компани |
Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
|
PT1082109E
(pt)
*
|
1998-04-29 |
2004-10-29 |
Sumitomo Pharma |
Formulacao oral que compreende biguanidina e um acido organico
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US20040010134A1
(en)
*
|
2000-04-12 |
2004-01-15 |
Rosen Craig A. |
Albumin fusion proteins
|
FR2796551B1
(fr)
*
|
1999-07-23 |
2003-07-25 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
FR2796940B1
(fr)
*
|
1999-07-26 |
2005-04-08 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
JP2003520759A
(ja)
*
|
1999-08-31 |
2003-07-08 |
アンドルックス ファーマスーティカルズ インコーポレーテッド |
単位核を有する徐放性錠剤
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
JP5183844B2
(ja)
*
|
1999-11-03 |
2013-04-17 |
ブリストル−マイヤーズ スクイブ カンパニー |
糖尿病の治療方法
|
WO2001034148A1
(fr)
*
|
1999-11-11 |
2001-05-17 |
Kyorin Pharmaceutical Co., Ltd. |
Preparations solides pour administration orale
|
FR2802813A1
(fr)
*
|
1999-12-23 |
2001-06-29 |
Aventis Pharma Sa |
Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6296874B1
(en)
*
|
2000-05-01 |
2001-10-02 |
Aeropharm Technology Incorporated |
Core formulation comprising troglitazone and abiguanide
|
US6270797B1
(en)
*
|
2000-05-18 |
2001-08-07 |
Usv Limited |
Sustained release pharmaceutical composition containing glipizide and method for producing same
|
FR2809310B1
(fr)
*
|
2000-05-26 |
2004-02-13 |
Centre Nat Rech Scient |
Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
|
WO2002012177A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Igor Anatolievich Pomytkin |
Composition of metformin with succinic acid or salts thereof and method for treating diabetes
|
HUP0302700A3
(en)
|
2000-08-07 |
2005-05-30 |
Ranbaxy Signature Llc Princeto |
Liquid formulation of metformin and its use
|
WO2002028181A1
(en)
*
|
2000-10-02 |
2002-04-11 |
Usv Limited |
Sustained release pharmaceutical compositions containing metformin and method of its production
|
US6451808B1
(en)
|
2000-10-17 |
2002-09-17 |
Depomed, Inc. |
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
FR2816841B1
(fr)
*
|
2000-11-22 |
2004-02-06 |
Lipha |
Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
|
FR2818906B1
(fr)
*
|
2000-12-29 |
2004-04-02 |
Dospharma |
Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
|
FR2818908B1
(fr)
*
|
2000-12-29 |
2004-04-02 |
Dospharma |
Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
|
CA2434169C
(en)
|
2001-01-12 |
2011-03-15 |
Sun Pharmaceutical Industries Limited |
Spaced drug delivery system
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
EP1377276B1
(en)
*
|
2001-04-10 |
2011-10-05 |
Sun Pharma Advanced Research Company Limited |
Timed pulse release composition
|
WO2002097038A2
(en)
*
|
2001-05-25 |
2002-12-05 |
Human Genome Sciences, Inc. |
Chemokine beta-1 fusion proteins
|
WO2002098409A1
(en)
*
|
2001-06-07 |
2002-12-12 |
Wyeth |
Combination therapy for type ii diabetes or syndrome x
|
IN192180B
(es)
*
|
2001-09-28 |
2004-03-06 |
Ranbaxy Lab |
|
EP1435931A2
(en)
*
|
2001-09-28 |
2004-07-14 |
Sun Pharmaceuticals Industries Ltd. |
Dosage form for treatment of diabetes mellitus
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
WO2003059934A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
DK1463751T3
(da)
*
|
2001-12-21 |
2013-08-26 |
Human Genome Sciences Inc |
Albuminfusionsproteiner.
|
ATE361065T1
(de)
*
|
2002-01-25 |
2007-05-15 |
Silanes Sa De Cv Lab |
Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes
|
US20030220301A1
(en)
*
|
2002-02-14 |
2003-11-27 |
Sonus Pharmaceuticals, Inc. |
Metformin salts of lipophilic acids
|
PT1476138E
(pt)
*
|
2002-02-21 |
2012-02-14 |
Valeant Internat Barbados Srl |
Formulações de libertação modificada de pelo menos uma forma de tramadol
|
US8323692B2
(en)
*
|
2002-02-21 |
2012-12-04 |
Valeant International Bermuda |
Controlled release dosage forms
|
US20030187074A1
(en)
*
|
2002-03-04 |
2003-10-02 |
Javed Hussain |
Oral compositions for treatment of diabetes
|
US20030219482A1
(en)
*
|
2002-03-21 |
2003-11-27 |
Chaudhari Sunil Sudhakar |
Multiparticulate compositions for once-a-day administration
|
US20030224046A1
(en)
*
|
2002-06-03 |
2003-12-04 |
Vinay Rao |
Unit-dose combination composition for the simultaneous delivery of a short-acting and a long-acting oral hypoglycemic agent
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
AU2003281181A1
(en)
*
|
2002-07-11 |
2004-02-02 |
Takeda Pharmaceutical Company Limited |
Process for producing coated preparation
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US7785627B2
(en)
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
EP1608341A1
(en)
*
|
2003-03-21 |
2005-12-28 |
Ranbaxy Laboratories, Ltd. |
Water-soluble tablets of metformin
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
CA2536111A1
(en)
*
|
2003-07-24 |
2005-02-03 |
Wockhardt Limited |
Oral compositions for treatment of diseases
|
FR2858556B1
(fr)
*
|
2003-08-06 |
2006-03-10 |
Galenix Innovations |
Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
AU2004285531A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption of metformin
|
EP1591114A1
(en)
*
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
KR100657785B1
(ko)
|
2005-02-19 |
2007-04-16 |
한국유나이티드제약 주식회사 |
글리메피리드, 메트포르민 및 은행엽엑스를 함유하는 약학적 조성물
|
MXPA05009633A
(es)
*
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
CN105152983A
(zh)
*
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
JP5292404B2
(ja)
*
|
2007-09-21 |
2013-09-18 |
ハンオル バイオファーマ カンパニー,リミテッド |
N,n−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
|
KR101104912B1
(ko)
|
2008-01-08 |
2012-01-12 |
한올바이오파마주식회사 |
N,n―디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
|
FR2928836B1
(fr)
*
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
BRPI0822909B8
(pt)
|
2008-06-26 |
2021-05-25 |
Laboratorios Silanes S A De C V |
sal de glicinato de metformina para o controle da glicose sanguínea
|
US20110021634A1
(en)
|
2009-06-18 |
2011-01-27 |
Patel Pranav Dushyant |
Processes for preparing metformin hydrochloride
|
WO2011008054A2
(ko)
*
|
2009-07-17 |
2011-01-20 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 부틸산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
KR20110007984A
(ko)
*
|
2009-07-17 |
2011-01-25 |
한올바이오파마주식회사 |
N,n―디메틸 이미도디카르본이미딕 디아미드의 프로피온산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
WO2011049400A2
(ko)
*
|
2009-10-23 |
2011-04-28 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
|
US8581001B2
(en)
|
2010-04-16 |
2013-11-12 |
Codman & Shurtleff |
Metformin-cysteine prodrug
|
WO2011154975A2
(en)
|
2010-06-08 |
2011-12-15 |
Cadila Healthcare Limited |
Pharmaceutical compositions of metformin
|
US8440723B2
(en)
*
|
2011-05-11 |
2013-05-14 |
Banavara L. Mylari |
Metformin salts of salicylic acid and its congeners
|
CN105017092A
(zh)
*
|
2011-11-23 |
2015-11-04 |
黎波 |
二甲双胍与2,5-二羟基苯磺酸盐以及二甲双胍与2,5-二羟基苯磺酸盐的复方组合物
|
WO2014008374A2
(en)
*
|
2012-07-06 |
2014-01-09 |
Thetis Pharmaceuticals Llc |
Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents
|
IN2015KN00076A
(es)
*
|
2012-07-10 |
2015-07-31 |
Thetis Pharmaceuticals Llc |
|
US9815777B2
(en)
|
2013-09-22 |
2017-11-14 |
Jiva Pharma, Inc. |
Metformin salts to treat Type2 diabetes
|
US10166246B2
(en)
|
2014-05-27 |
2019-01-01 |
City Of Hope |
TGR5 agonist complexes for treating diabetes and cancer
|
US20170281607A1
(en)
|
2016-04-01 |
2017-10-05 |
University Of Limerick |
Pharmaceutical compositions and methods for the treatment of diabetes
|
WO2017195086A1
(en)
*
|
2016-05-10 |
2017-11-16 |
Sarath Kumar Kamavarapu |
Salts of n,n-dimethylbiguanide and preparation methods thereof
|
WO2018034627A1
(en)
|
2016-08-18 |
2018-02-22 |
İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi |
Pharmaceutical composition of antidiabetic tablet
|
CN112955964B
(zh)
|
2018-06-14 |
2023-10-27 |
阿斯利康(英国)有限公司 |
用二甲双胍药物组合物降低血糖的方法
|
CN113105367B
(zh)
*
|
2021-03-30 |
2022-08-02 |
广州大学 |
一类二甲双胍盐及其制备方法和应用
|